OP24 Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn’s disease

Authors :: Mathurin Fumery
Franck Brazier
Laurent Siproudhis
A. Buisson
D. Laharie
Anne Bozon
Pauline Veyrard
Stephanie Viennot
Jérôme Filippi
Xavier Roblin
Lieven Pouillon
Bernard Flourié
L Peyrin-Biroulet
Stéphane Nancey
Romain Altwegg
Lucile Boivineau
Xavier Treton
Guillaume Bouguen
Florian Poullenot
Cyrielle Gilletta
Source :: Journal of Crohn's and Colitis. 13:S016-S016
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.

Subjects :: Crohn's disease
medicine.medical_specialty
business.industry
Internal medicine
Ustekinumab
Gastroenterology
medicine
General Medicine
medicine.disease
business
medicine.drug

Full Text Access

Tools